PharmaTrace Secures $300,000 in HBAR Funding for Next-Gen Drug Tracking

icon币界网
Share
Share IconShare IconShare IconShare IconShare IconShare IconCopy

According to Bijié Wǎng, PharmaTrace has raised 300,000 HBAR through the Thrive Hedera initiative to support its development. The company, a regulated decentralized physical infrastructure network (DePIN) for pharmaceutical supply chains, plans to transition from Hyperledger Fabric to a public permissioned architecture built on Hedera. The funding aims to enhance interoperability and privacy for sensitive data, with public verification of supply chain events as a core feature. Hedera’s hashgraph technology will support key components, including tokenized product serialization via HTS and verifiable event logging via HCS. Mirror nodes on Hedera will allow regulators and authorized parties to validate events without accessing confidential systems. PharmaTrace also outlined plans for a utility token tied to reporting accuracy, platform access, and future governance, and intends to contribute to the Hedera ecosystem in regulated supply chain areas.

Disclaimer: The information on this page may have been obtained from third parties and does not necessarily reflect the views or opinions of KuCoin. This content is provided for general informational purposes only, without any representation or warranty of any kind, nor shall it be construed as financial or investment advice. KuCoin shall not be liable for any errors or omissions, or for any outcomes resulting from the use of this information. Investments in digital assets can be risky. Please carefully evaluate the risks of a product and your risk tolerance based on your own financial circumstances. For more information, please refer to our Terms of Use and Risk Disclosure.